Please login to the form below

Not currently logged in
Email:
Password:

hVIVO

This page shows the latest hVIVO news and features for those working in and with pharma, biotech and healthcare.

Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more

Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more

UK BIOTECH. Universal flu vaccine shows promise in phase 2. UK next-generation vaccines company hVIVO has unveiled promising results for its universal flu vaccine candidate. ... FLU-v is being developed by Imutex, hVIVO's 49% joint venture with PepTcell

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics